Cargando…

Editorial: Novel biomarkers for anticancer therapy

Detalles Bibliográficos
Autores principales:	Wang, Ting, Chen, Zhe-Sheng, Shi, Chen, Ouyang, Liang, Xiao, Hongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853068/ https://www.ncbi.nlm.nih.gov/pubmed/36686681 http://dx.doi.org/10.3389/fphar.2022.1109761

Ejemplares similares

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
por: Lin, Xiaoping, et al.
Publicado: (2022)

Editorial: Novel Targets and Biomarkers in Solid Tumors
por: Shi, Zhi, et al.
Publicado: (2019)

Editorial: Discovering novel anticancer molecules and revealing the pharmacological mechanism of gastrointestinal carcinoma
por: Xia, Yong, et al.
Publicado: (2022)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Cytoskeleton in the focus of anti-cancer therapy: In a search of novel biomarkers and combinatorial therapy approaches
por: Vorobjev, I.
Publicado: (2022)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Editorial: Molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges
por: Abdel-Wahab, Basel A., et al.
Publicado: (2023)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Jaafari, Abdeslam, et al.
Publicado: (2022)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
por: Chen, Nianzhi, et al.
Publicado: (2022)

Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics
por: Giuliani, Anna Lisa, et al.
Publicado: (2021)

Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells
por: Bai, Yinliang, et al.
Publicado: (2021)

Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
por: Yang, Xinyu, et al.
Publicado: (2018)

Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy?
por: Wang, Muyun, et al.
Publicado: (2021)

MicroRNA as an Important Target for Anticancer Drug Development
por: Fu, Zhiwen, et al.
Publicado: (2021)

Editorial: Nanoparticles in Cancer Therapy-Novel Concepts, Mechanisms, and Applications
por: Mu, Qingxin, et al.
Publicado: (2019)

Editorial: Next-Generation Cancer Therapies Based on a (R)evolution of the Biomarker Landscape
por: Cerella, Claudia, et al.
Publicado: (2022)

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
por: Hou, Jun, et al.
Publicado: (2022)

Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
por: Shi, Jinfeng, et al.
Publicado: (2020)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Editorial: Medicinal plants in the treatment of gastrointestinal cancers: How can OMICS and other advanced approaches help in understanding their mechanisms of action?
por: Feng, Yibin, et al.
Publicado: (2022)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Identification of Circular RNAs Circ_0005008 and Circ_0005198 in Plasma as Novel Biomarkers for New-Onset Rheumatoid Arthritis
por: Ouyang, Qingqing, et al.
Publicado: (2021)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Targeting Tumor Perfusion and Oxygenation to Improve the Outcome of Anticancer Therapy
por: Jordan, Bénédicte F., et al.
Publicado: (2012)

Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy
por: Jin, Fangfang, et al.
Publicado: (2022)

Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel in vivo and in vitro
por: Chen, Haifang, et al.
Publicado: (2022)

Editorial: Mitochondrial therapy in neurodegeneration
por: Kalani, Anuradha, et al.
Publicado: (2023)

The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
por: Yuan, Tao, et al.
Publicado: (2018)

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies
por: Taldaev, Amir, et al.
Publicado: (2023)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrd147aogipr5avubop7ggfe9g